To further explore the effects of inhibiting necroptosis in AKI, we added the RIP1 inhibitor Nec-1 (50 μm) to the cell culture medium before HR treatment and extracted cellular protein from the H6R6 group. Here, RIPK1 is linked to acute kidney injury.